Tweenvest Stocks

OncoZenge AB (publ) (OM: ONCOZ)

Health Care · Pharmaceuticals · SE

Skr3.79

-9.33% today · -24.0% 1Y

OncoZenge AB (publ) (OM: ONCOZ) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $11.54M and employs 1 people.

Over the last twelve months the share price has lost 24.0%, trading between 3.10 and 10.28.

Tweenvest scores OncoZenge AB (publ) across four factors: quality 35/100, value 59/100. Its strongest factor is value.

ONCOZ price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$11.54M
Revenue (TTM)
$616.28K
P/E
—
EPS
-2.00
Dividend yield
—
Beta (5Y)
1.35
52-week high
Skr10.28
52-week low
Skr3.10
Avg volume (3M)
—
Shares outstanding
27.60M
Employees
1
Next earnings
—

About OncoZenge AB (publ)

OncoZenge AB (publ) operates as a pharmaceutical company with a focus on developing medical solutions that offer supportive care for cancer patients. A significant product in its pipeline is BupiZenge, which has successfully completed Phase 2 clinical trials for the management of oral mucositis. This company was established in 2020 and conducts its operations from its headquarters in Bromma, Sweden. Notably, OncoZenge AB (publ) is a subsidiary entity of Moberg Pharma AB (publ).

ISIN
SE0015504097
Founded
2020
Listed since
Feb 12, 2021
Exchange
OMX Nordic Exchange Stockholm
Currency
SEK
CompanyMarket capPriceDay
Hepion Pharmaceuticals, Inc.OTCPK: HEPA$11.79M$0.12+48.15%
AcuCort AB (publ)XSAT: ACUC$11.70MSkr0.40-19.88%
Argenica Therapeutics LimitedASX: AGN$11.65MAU$0.13-13.33%
Aspire-Lakewood Holdings, Inc.NasdaqCM: ASBP$11.64M$7.64-7.95%
Silva Pharmaceuticals LimitedDSE: SILVAPHL$11.53MTk10.40-16.80%
IDT Australia LimitedASX: IDT$11.33MAU$0.04-7.32%
Together Pharma LtdTASE: TGTR$11.32M₪2.00-3.71%
Pharmaids Pharmaceuticals LimitedBSE: 524572$11.23MRs30.81+2.19%

Browse every Pharmaceuticals company →

Figures last refreshed Oct 11, 2026.